cis Effects of CTG Expansion in Myotonic Dystrophy Type 1

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 55-78

  Reddy, Sita ^a   Paul, Sharan ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748949952     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50005-3     Document Type: Chapter

References (126)

1. Steinert H. Myopathologische Beitrage1. Uber das klinischeund anatomische Bild des Muskelschwunds der Myotoniker. Dtsch. Z. Nervenheilkd. 1909, 37:58-104.
2. Batten F.E., Gibb H.P. Myotonia atrophica. Brain 1909, 32:187-205.
3. Harper P.S. Myotonic Dystrophy 1989, Saunders, Philadelphia. 2nd ed.
4. Harper P.S. Myotonic dystrophy 2001, Saunders, London.
5. Roses A.D., Harper P.S., Bossen E.H. Myotonic muscular dystrophy. The Handbook of Clinical Neurology 1979, 485-532. Ch. 13, North-Holland, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
6. Fleischer B. Uber myotonische Dystrophie. Munch. Med. Wochenschr. 1917, 64:1630.
7. Howeler C.J., Busch H.F., Geraedts J.P., Niermeijer M.F., Staal A. Anticipation in myotonic dystrophy: Fact or fiction?. Brain 1989, 112:779-797.
8. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburtani H., Hunter K., Stanton V.P., Thirion J.-P., Hudson T., Sohn R., Zemelman b., Snell R.G., Rundle S.A., Crow S., Davies J., Selbourne P.J.B., Jones C., Juxonen V., Johnson K., Harper P.S., Duncan D.J., Housman D.E. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
9. Fu Y.-H., Pizutti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., De Jong P., Wieringa B., Korneluk R., Perryman M.B., Epstein H.F., Caskey C.T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
10. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., Leblond S., Earle-Macdonald J., de Jong P.J., Wieringa B., Korneluk R.G. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
11. Boucher C.A., King S.K., Carey N., Krahe R., Winchester C.L., Rahman S., Creavin T., Meghji P., Bailey M.E.S., Chartier F.L. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum. Mol. Genet. 1995, 4:1919-1925.
12. Barcelo J.M., Mahadeyan M.S., Tsilfidis C., MacKenzie A.E., Korneluk R.G. Intergenerational stability of the myotonic dystrophy protomutation. Hum. Mol. Genet. 1993, 2:705-709.
13. Harley H., Rundle S.A., MacMillan J.C., Myring J., Brook J.D., Crow S., Reardon W., Fenton I., Shaw D.J., Harper P.S. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 1993, 52:1164-1174.
14. Sarkar P.S., Chang H-C, Boudi B.F., Reddy S. CTG repeats show bimodal amplification in E.coli. Cell 1998, 95:531-540.
15. Machuca-Tzili L., Brook D., Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 2005, 32:1-18.
16. Sarnat H.B., O'Connor T., Byrne P.A. Clinical effects of myotonic dystrophy on pregnancy and the neonate. Arch. Neurol. 1976, 7:459-465.
17. Fragola P.V., Luzi M., Calo L., Antonini G., Borzi M., Frongillo D., Cannata D. Cardiac involvement in myotonic dystrophy. Am. J. Cardiol. 1994, 74:1070-1072.
18. Hawley R.J., Milner M.R., Gottdiener J.S., Cohen A. Myotonic heart disease: A clinical follow-up. Neurology 1991, 41:259-262.
19. Melacini P., Villanova C., Menegazzo E., Novelli G., Danieli G., Rizzoli G., Fasoli G., Angelini C., Buja G., Miorelli M., Dallapiccola B., Dalla Volta S. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J. Am. Coll. Cardiol. 1995, 25:239-245.
20. Tokgozoglu L.S., Ashizawa T., Pacifico A., Armstrong R.M., Epstein H.F., Zoghbi W.A. Cardiac involvement in a large kindred with myotonic dystrophy. JAMA 1995, 274:813-819.
21. Forsberg H., Olofsson B-O, Eriksson A., Andersson S. Cardiac involvement in congenital myotonic dystrophy. Br. Heart J. 1990, 63:119-121.
22. Sonaglioni G., Curatola L., Bollettini G., Agostini L., Franchetta G., Palestini N., Pignotti M., Floris B. Echocardiographic findings in dystrophia myotonica (Steinert's disease). G. Ital. Cardiol. 1984, 14:551-556.
23. Lin A.E., Mitchell F.M., Fitz R.W., Doyle J.J. Dilated cardiomyopathy in myotonic dystrophy. J. Am. Coll. Cardiol. 1989, 1:262-263.
24. Premawardhana L.D., Thirunavakarasu G. Myotonia dystrophica: First presentation as severe left ventricular failure complicating dilated cardiomypathy. Postgrad. Med. J. 1992, 795:67.
25. Fall F.H., Young W.W., Power J.A., Faulkner C.S., Hettleman B.D., Robb J.F. Severe congestive heart failure and cardiomyopathy as a complication of myotonic dystrophy inpregnancy. Obstet. Gynecol. 1990, 76:481-485.
26. Pentimone F., Del Corso L., Vannini A., Mori L., Moruzzo D. Dilated cardiomyopathy and visceral anomalies in myotonic dystrophy. Minerva Cardioangiol. 1990, 38:231-234.
27. Igarashi H., Momoi M.Y., Yamagata T., Shiraishi H., Eguchi I. Hypertrophic cardiomyopathy in congenital myotonic dystrophy. Pediatr. Neurol. 1998, 18:366-369.
28. Calderon R. Myotonic dystrophy: A neglected cause of mental retardation. J Pediatr. 1966, 68:423-431.
29. Palmer B.W., Boone K.B., Chang L., Lee A., Black S. Cognitive deficits and personality patterns in maternally versus paternally inheritied myotonic dystrophy. J. Clin Exp Neuropsychol. 1994, 16:784-795.
30. Colombo G., Perini G.I., Miotti M.V., Armani M., Angelini C. Cognitive and psychiatric evaluation of 40 patients with myotonic dystrophy. Ital. J. Neurol. Sci. 1992, 13:53-58.
31. Censori B., Danni M., Del Pesce M., Provinciali L. Neuropsychological profile in myotonic dystrophy. J. Neurol. 1990, 237:251-256.
32. Turnpenny P., Clark C., Kelly K. Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification. J. Med. Genet. 1994, 31:300-305.
33. Goossens E., Steyaert J., De Die-Smulders C., Willekens D., Fryns J.P. Emotional and behavioral profile and child psychiatric diagnosis in the childhood type of myotonic dystrophy. Genet. Couns. 2000, 11:317-327.
34. Giubilei F., Antonini G., Bastianello S., Morino S., Paolillo A., Fiorelli M., Ferretti C., Fieschi C. Excessive daytime sleepiness in myotonic dystrophy. J. Neurol Sci. 1999, 164:60-63.
35. Garcia-Alix A., Cabanas F., Morales C., Pellicer A., Echevarria J., Paisan L., Quero J. Cerebral abnormalities in congenital myotonic dystrophy. Pediatr. Neurol. 1991, 1:28-32.
36. Ono S., Kanda F., Takahashi K., Fukuoka Y., Jinnai K., Kurisaki H., Mitake S., Inagaki T., Nagao K. Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: A clinicopathological correlation. Acta Neuropathol. (Berlin) 1995, 89:122-125.
37. Ono S., Kanda F., Takahashi K., fukuoka Y., Jinnai K., Kurisaki H., Mitake S., Inagaki T., Nagao K. Neuronal loss in the medullary reticular formation in myotonic dystrophy: A clinicopathological study. Neurology 1996, 46:228-231.
38. Ono S., Takahashi K., Kanda F., Jinnai K., Fukuoka Y., Mitake S., Inagaki T., Kurisaki H., Nagao K., Shimizu N. Decrease of neurons in the medullary arcuate nucleus in myotonic dystrophy. Acta Neuropathol. (Berlin) 2001, 102:89-93.
39. Di Costanzo A., Di Salle F., Santoro L., Bonavita V., Tedeschi G. Brain MRI features of congenital and adult-form myotonic dystrophy type 1: Case-control study. Neuromuscul. Disord. 2002, 12:476-483.
40. Kiuchi A., Otsuka N., Namba Y., Nakano I., Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol. (Berlin) 1991, 1:1-5.
41. Yoshimura N., Otake M., Igarashi K., Matsunaga M., Takebe K., Kudo H. Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy. Clin. Neuropathol. 1990, 5:234-239.
42. Yoshimura N. Alzheimer's neurofibrillary changes in the olfactory bulb in myotonic dystrophy. Clin. Neuropathol. 1990, 9:240-243.
43. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Otto M., Heine R. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness and cataracts. Neurology 1994, 44:1448-1452.
44. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Speich N., Reiners K. Proximal myotonic myopathy: Clinical features of amultisystem disorder similar to myotonic dystrophy. Arch. Neurol. 1995, 52:25-31.
45. Moxley R.T. Proximal myotonic myopathy: Minireview of a recently delineated clinical disorder. Neuromuscul. Disord. 1996, 6:87-93.
46. Day J.W., Ricker K., Jacobsen J.F., Rasmussen L.J., Dick K.A., Kress W., Schneider C., Koch M.C., Beilman G.J., Harrison A.R., Dalton J.C., Ranum L.P.W. Myotonic dystrophy type 2. Neurology 2003, 60:657-664.
47. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
48. Day J.W., Ranum L.P.W, RNA pathogenesis of the myotonic dystrophies. Neuromuscul. Disord. 2005, 15:5-16.
49. Meola G., Sansone V., Marinou K., Cotelli M., Moxley R.T., Thornton C.A., De Ambroggi L. Proximal myotonic myopathy: A syndrome with favourable prognosis?. J. Neurol Sci. 2002, 193:89-96.
50. Hund E., Jansen O., Koch M.C., Ricker K., Fogel W., Niedermaier N., Otto M., Kuhn E., Meinck H.M. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology 1997, 48:33-37.
51. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
52. Seznec H., Agbulut O., Sergeant N., Savouret C., Ghestem A., Tabti N., Willer J.C., Ourth L., Duros C., Brisson E., Fouquet C., Butler-Browne G., Delacourte A., Junien C., Gourdon G. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 2001, 10:2717-2726.
53. Caskey C.T., Swanson M.S., Timchenko L.T. Myotonic dystrophy: Discussion of molecular mechanism. Cold Spring Harb. Symp. Quant. Biol. 1996, 61:607-614.
54. Taneja K.L., McCurrach M.E., Shalling M., Housman D., Singer R. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 1995, 128:995-1002.
55. Mariappan S.V., Garcoa A.E., Gupta G. Structure and dynamics of the DNA hairpins formed by tandemly repeated CTG triplets associated with myotonic dystrophy. Nucleic Acids Res. 1996, 15:775-783.
56. Timchenko L.T., Miller J.W., Timchenko N.A., DeVore D.R., Datar K.V., Lin L., Roberts R., Caskey C.T., Swanson M.S. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996, 24:4407-4414.
57. Michalowski S., Miller J.W., Urbinati C.R., Paliouras M., Swanson M.S., Griffith J. Visualization of doublestranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res. 1999, 27:3534-3542.
58. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expandedprepeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 2002, 11:805-814.
59. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester CUG-BP1 and alter protein levels and activity of CUG-BP1. J. Biol. Chem. 2001, 276:7820-7826.
60. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stenberg M.G., Byrne B.J., Thornton C.A., Swanson M.S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 2000, 19:4439-4448.
61. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 2001, 10:2165-2170.
62. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell. 2002, 1:35-44.
63. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type I myotonic dystrophy due to misregulated alternative splicing. Mol. Cell. 2002, 10:45-53.
64. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
65. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
66. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P.W., Day J.W. Insulin receptor splicing alteration in Myotonic dystrophy type 2. Am. J. Hum. Genet. 2004, 74:1309-1313.
67. Buj-Bello A., Furling D., Tronchere H., Laporte J., Lerouge T., Butler-Browne G.S., Mandel J-L. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 cells. Hum. Mol. Genet. 2002, 11:2297-2307.
68. Jiang H., Mankodi A., Swanson M.S., Moxley R.T., Thornton C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 2004, 13:3079-3088.
69. Timchenko N.A., Patel R., Iakova P., Cai Z-J., Quan L., Timchenko L.T. Overexpression of CUG triplet repeat binding protein, CUG-BP1, in mice inhibits myogenesis. J. Biol Chem. 2004, 279:13129-13139.
70. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 2005, 14:1539-1547.
71. Ho T.H., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO. J. 2004, 23:3103-3112.
72. Dansithong W., Paul S., Comai L., Reddy S. MBNL1 is the primary determinant of focus formation and aberrant IR splicing in DM1. J. Biol. Chem. 2005, 280:5773-5780.
73. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
74. Ebralidze A., Wang Y., Petkova K., Ebralidse R., Junghans R.P. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004, 303:383-387.
75. Shimizu K., Chen W., Ashique A.M., Moroi R., Li Y-P. Molecular cloning, developmental, expression, promoter analysis and functional characterization of the mouse CNBP gene. Gene 2003, 307:51-62.
76. Lam L.T., Pham Y.C.N., Man N.T., Morris G.E. Characterization of the monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exlusively in muscle heart. Hum. Mol. Genet. 2000, 9:2167-2173.
77. Sarkar P.S., Han J., Reddy S. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues. Neuromuscul. Disord. 2004, 14:497-506.
78. Alwazzan M., Hamshere M.G., Lennon G.G., Brook J.D. Six transcripts map within 200 kilobases of the myotonic dystrophy expanded repeat. Mamm. Genome 1998, 9:485-487.
79. Fu Y.-H., Friedman D.L., Richards S., Pearlman J.A., Gibbs R.A., Pizutti A., Ashizawa T., Perryman M.B., Scarlato G., Fenwick R.G.J., Caskey C.T. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993, 260:235-237.
80. Wang J., Pegoraro E., Menegazzo E., Gennarelli M., Hoop R.C., Angelini C., Hofmann E. Myotonic dystrophy: Evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 1995, 4:599-606.
81. Wang Y.H., Amirhaeri S., Kang S., Wells R.D., Griffith J.D. Preferential nucleosome assembly at DNA triplet repeats from myotonic dystrophy gene. Science 1994, 265:669-671.
82. Otten A.D., Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin, structure. Proc. Natl. Acad. USA 1995, 92:5465-5469.
83. Klesert T.R., Otten A.D., Bird T.D., Tapscott S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHF. Nat. Genet. 1997, 16:402-407.
84. Thornton C.A., Wymer J.P., Simmons Z., McClain C., Moxley R.T. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat. Genet. 1997, 16:407-409.
85. Alwazzan M., Newman E., Hamshere M.G., Brook J.D. Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum. Mol. Genet. 1999, 8:1491-1497.
86. Jansen G., Groenen P.J.T.A., Bachner D., Jap P.H.K., Coerwinkel M., Oerlemans F., Broek W., Gohlsch B., Pette D., Plomp J.J., Molenaar P.C., Nederhoff M.G.J., Echteld C., Dekker M., Berns A., Hameister H., Weiringa B. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 1996, 13:423-442.
87. Zhao Y., Loyer P., Li H., Valentine V., Kidd V., Kraft A.S. Cloning and chromosomal location of a novel member of the myotonic dystrophy family of protein kinases. J. Biol. Chem. 1997, 272:10013.
88. Shimizu M., Wang W., Walch E.T., Dunne P.W., Epstein H.F. Rac-1 and Raf-1 kinases components of distinct signaling pathways, activate myotonic dystrophy protein kinase. FEBS Lett. 2000, 475:273-277.
89. Jin S., Shimizu M., Balasubramanyam A., Epstein H.F. Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells. Cell Motil. Cytoskel. 2000, 45:133-148.
90. Jansen G., Mahadevan M., Amemiya C., Wormskamp N., Segers B., Hendriks W., O'Hoy K., Baird S., Sabourin L., Lennon G., Jap P.L., Iles D., Coerwinkel M., Hofker M., Carrano A.V., de Jong P.J., Korneluk R.G., Wieringa B. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat. Genet. 1992, 1:261-266.
91. Mahadevan M.S., Amemiya C., Jansen G., Sabourin L., Baird S., Neville C.E., Wormskamp N., Segers B., Batzer M., Lamerdin J., et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. Mol. Genet. 1993, 2:299-304.
92. Kamps M.P., Taylor S.S., Sefton B.M. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinases have homologous ATP binding sites. Nature 1984, 310:589-592.
93. Hanks S.K., Quinn A.M., Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 1988, 241:42-52.
94. Reddy S., Smith D.B.J., Rich M.M., Leferovich J.M., Reilly P., Davis B.D., Tran K., Rayrurn H., Bronson R., Cros D., Balice-Gordon R.J., Housman D. Mice lacking the myotonic dystrophy kinase develop a late onset myopathy. Nat. Genet. 1996, 13:423-442.
95. 2+ homeostasis in skeletal muscle cells. J. Clin. Invest. 1997, 100:1440-1447.
96. Jacobs A.E.M., Benders A.A., Oosterhof A., Veerkamp J.H., Van Mier P., Wevers R.A., Joosten E.M.G. The calcium homeostasis and membrane potential of cultured muscle cells from patients with myotonic dystrophy. Biochim. Biophys. Acta 1990, 1096:14-19.
97. Benders A.A., Wevers R.A., Veerkamp J.H. Ion transport I human skeletal muscle cells: Disturbances in myotonic dystrophy and Brody's disease. Acta Physiol. Scand. 1996, 156:355-367.
98. Rudel R., Ruppersberg J.P., Spittelmeister W. Abnormalities of the fast sodium current in myotonic dystrophy, recessive generalized myotonia and adynamia episodica. Muscle Nerve 1989, 12:281-287.
99. ? conductance in resealed muscle fiber segments from patients with myotonic dystrophy. J. Physiol. London 1990, 425:391-405.
100. Mounsey J.P., Mistry D.J., Ai C.W., Reddy S., Moorman J.R. Skeletal muscle sodium channel gating in mice deficient, in myotonic dystrophy protein kinase. Hum. Mol. Genet. 2000, 9:2313-2320.
101. Reddy S., Mistry D.J., Wang Q.C., Geddis J.M., Kutchai H.C., Moorman J.R., Mounsey J.P. Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Muscle Nerve 2002, 25:850-857.
102. Wissman A., Ingles J., McGee J.D., Mains P.E. Caenorhabditis elegans LET-502 is related to Rho-binding kinases and human myotonic dystrophy kinase and interacts genetically with a homolog of the regulatory subunit of smooth muscle myosin phosphatase to affect cell shape. Genes Dev. 1997, 11:409-422.
103. Timchenko L., Nastainczyk W., Schneider T., Patel B., Hofman F., Caskey C.T. Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc. Natl. Acad. Sci. USA 1995, 92:5366-5370.
104. Mounsey J.P., Xy P., John J.E., Horne L.T., Gilbert J., Roses A.D., Moorman J.R. Modulation of skeletal muscle sodium channels by human myotonin protein kinase. J. Clin. Invest. 1995, 95:2379-2384.
105. Berul C.I., Aronovitz M.J., Saba S., Housman D., Mendelsohn M., Reddy S. Atrioventricular conduction abnormalities are observed in mice lacking the myotonic dystrophy kinase. J. Clin Invest. 1999, 103:R1-R7.
106. Saba S., VanderBrink B.S., Luciano B., Aronovitz M.J., Berul C.I., Wang P. Localization of the site of conduction abnormality in a mouse model of myotonic dystrophy. J. Cardiovasc. Electrophysiol. 1999, 10:1214-1220.
107. Berul C.I., Maguire C.T., Gehrmann J., Ai C., Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J. Intern. Cardiovasc. Electrophysiol. 2000, 4:351-358.
108. Lee H.C., Patel M.K., Mistry D.J., Wang Q., Reddy S., Moorman J.R., Mounsey J.P. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase. Physiol. Genom. 2003, 12:147-157.
109. Kaliman P., Catalucci D., Lam J.T., Kondo R., Gutierrez J.C.P., Reddy S., Palacin M., Zorzano A., Chien K.R., Ruiz-Lozano P. Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocte sarcoplasmic reticulum. J. Biol. Chem. 2005, 280:8016-8021.
110. Muranyi A., Zhang R., Liu F., Hirano K., Ito M., Epstein H.F., Hartshorne D.J. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase activity. FEBS Lett. 2001, 493:80-84.
111. Schulz P.E., Mcintosh A.D., Kasten M.R., Wieringa B., Epstein H.F. A role for myotonic dystrophy protein kinase in synaptic plasticity. J. Neurophysiol. 2003, 89:1177-1186.
112. Kawakami K., Sato S., Ozaki H., Ikeda K. Six family genes-structure and function as transcription factors and their role in development. Bioessays 2000, 7:616-626.
113. Wallis D.E., Roessler E., Hehr U., Nanni L., Wiltshire T., Richieri-Costa A., Gillessen-Kaesbach G., Zackai E.H., Rommens J., Muenke M. Mutations in the homeodomain of the human XIX3 gene cause holoprosencephaly. Nat. Genet. 1999, 22:196-198.
114. Gallardo M.E., Lopez-Rios J., Fernaud-Espinosa I., Granadino B., Sanz R., Ramos C., Ayuso C., Seller M.J., Brunner H.G., Bovolenta P., Rodriguez, de Cordoba S. Genomic cloning and characterization of the human homeobox gene SIX6 reveals a cluster of SIX genes in chromosome 14 and associates XIX6 hemizygosity with bilateral anophthalmia and pituitary anomalies. Genomics 1999, 61:82-91.
115. Sarkar P.S., Appukuttan B., Han J., Ai C., Tsai W., Stout J.T., Reddy S. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 2000, 25:110-114.
116. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., Yuen E.C., Soriano P., Tapscott S.J. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy. Nat. Genet. 2000, 25:105-109.
117. Personius K.E., Nautiyal J., Reddy S. Loss of Six5 in mice is insufficient to cause myotonia or contractile abnormalities. Muscle Nerve 2004, 4:503-505.
118. Mistry D.J., Moorman J.R., Reddy S., Mounsey J.P. Skeletal muscle Na currents in mice heterozygous for Six5 deficiency. Physiol. Genom. 2001, 6:153-158.
119. Wakimoto H., Maguire C.T., Sherwood M.C., Vargas M.M., Sarkar P.S., Han J., Reddy S., Berul C.I. Characterization of cardiac conduction, system abnormalities in mice with targeted disruption of Six5 gene. J. Interv Cardiovasc. Electrophysiol. 2002, 7:127-135.
120. Babuty D., Fauchier L., Tena-Carbi D., Poret P., Leche J., Raynaud M., Fauchier J.P., Cosnay P. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?. Heart 1999, 82:634-637.
121. Ohto H., Kamada S., Tago K., Tominaga S.I., Ozaki H., SAto S., Kawakami K. Cooperation of Six and Eya in activation of their target genes through nuclear translocation of Eya. Mol. Cell. Biol. 1999, 19:6815-6824.
122. Sarkar P.S., Paul S., Han J., Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum. Mol. Genet. 2004, 13:1421-1431.
123. Bitgood M.J., Shen L., McMahon A.P. Sertoli cell signaling by desert hedgehog regulates the male germline. Curr. Biol. 1996, 6:298-304.
124. Loveland K.L., Schlatt S. Stem cell factor and c-kit in the mammalian testis: Lessons originating from mother nature's gene knockouts. J. Endocrinol. 1997, 153:337-344.
125. Packer A.L., Besmer P., Bachvarova R.F. Kit ligand mediates survival of type A speramtogonia and dividing spermatocytes in postnatal mouse testis. Mol. Reprod. Dev. 1995, 42:303-310.
126. Kirby R.J., Hamilton G.M., Finnegan D.J., Johnson K.J., Jarman A.P. Drosophila homolog of the myotonic dystrophy-associated gene. SIX5, is required for muscle and gonad development. Curr. Biol. 2001, 11:1044-1049.